azides has been researched along with Lung Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HY; Chao, SW; Chen, MY; Chiu, HW; Hu, FH; Huang, WJ; Juan, HF; Lin, P; Tang, YA; Wang, TW; Wang, YC; Wang, YJ; Yeh, YL | 1 |
| Choi, K; Han, SJ; Jeong, SY; Kim, K; Kim, SH; Koo, H; Kwon, IC; Lee, S; Lee, SJ; Min, HS; Na, JH; Yun, SH | 1 |
| Aboagye, EO; Fortt, R; Fortt, RR; Witney, TH | 1 |
| Fang, JM; Lee, YM; Lim, C; Liu, YC; Shie, JJ; Wong, CH | 1 |
| Elsabahy, M; Fan, J; Gonzalez, AM; Gustafson, TP; Hughes, DM; Johnson, R; Leininger, SE; Lenox, MW; Li, R; Nelson, LD; Pavía-Sanders, A; Pollack, SF; Raymond, JE; Wooley, KL; Zhang, F; Zhang, S; Zou, J | 1 |
| Layek, B; Prabha, S; Sadhukha, T | 1 |
| Kim, JH; Kim, K; Koo, H; Kwon, IC; Lee, H; Lee, KY; Lee, S; Na, JH; Shim, MK; Shin, ML; Yoon, HY | 1 |
| Ambudkar, SV; Bahr, JC; Bates, SE; Di Pietro, A; Macalou, S; Obrzut, T; Polgar, O; Robey, RW; Shukla, S | 1 |
| Choi, K; Hahn, SK; Jeong, SY; Kim, K; Kim, SH; Koo, H; Kwon, IC; Lee, S; Na, JH | 1 |
| Chapman, DV; Heyderman, E; Richardson, TC | 1 |
| Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Takagaki, S; Tsujimoto, S | 1 |
| Fossli, T; Jahnsen, T; Lange-Carter, CA; Malkinson, AM | 1 |
| Holmes, EH | 1 |
| Lem, VM; Lipscomb, MF; Toews, GB; Weissler, JC | 1 |
| Droms, KA; Haley, BE; Malkinson, AM | 1 |
| Biaglow, JE; Donahue, L; Varnes, ME | 1 |
16 other study(ies) available for azides and Lung Neoplasms
| Article | Year |
|---|---|
A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azides; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; Xenograft Model Antitumor Assays | 2014 |
Chemical tumor-targeting of nanoparticles based on metabolic glycoengineering and click chemistry.
Topics: Animals; Azides; Cell Line, Tumor; Chitosan; Click Chemistry; Hexosamines; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Male; Mice; Molecular Targeted Therapy; Nanoparticles | 2014 |
Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azides; Carboplatin; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activation; Female; Humans; Indoles; Lung Neoplasms; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2014 |
An azido-BODIPY probe for glycosylation: initiation of strong fluorescence upon triazole formation.
Topics: Azides; Boron Compounds; Cell Line, Tumor; Copper; Cyclization; Fluorescent Dyes; Glycoproteins; Glycosylation; Humans; Lung Neoplasms; Triazoles | 2014 |
Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers.
Topics: Alkynes; Animals; Azides; Bone Neoplasms; Catalysis; Cell Line, Tumor; Copper; Drug Carriers; Drug Liberation; Esters; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Mice; Micelles; Models, Molecular; Molecular Conformation; Nanoparticles; Osteosarcoma; Paclitaxel; Polyethylene Glycols; Polymers; Tissue Distribution | 2015 |
Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Azides; Cell Engineering; Cell Line, Tumor; Click Chemistry; Cyclooctanes; Drug Delivery Systems; Female; Fluorescent Dyes; Humans; Lung; Lung Neoplasms; Mesenchymal Stem Cells; Mice, SCID; Optical Imaging; Ovarian Neoplasms; Ovary; Paclitaxel; Theranostic Nanomedicine | 2016 |
Artificial Chemical Reporter Targeting Strategy Using Bioorthogonal Click Reaction for Improving Active-Targeting Efficiency of Tumor.
Topics: Azides; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chitosan; Click Chemistry; Female; Humans; Lung Neoplasms; Nanoparticles | 2017 |
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Biological Transport; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Immunoblotting; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Proteins; Prazosin | 2009 |
Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles.
Topics: Animals; Azides; Cell Line, Tumor; Click Chemistry; Copper; Drug Delivery Systems; Hexosamines; Humans; Liposomes; Lung Neoplasms; Mice; Nanoparticles; Polysaccharides; Sialic Acids; Xenograft Model Antitumor Assays | 2012 |
Immunoperoxidase techniques: the deleterious effect of sodium azide on the activity of peroxidase conjugates.
Topics: Antibodies; Azides; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Enzyme-Linked Immunosorbent Assay; Horseradish Peroxidase; Humans; Immunoenzyme Techniques; Lung Neoplasms; Peroxidases; Sodium Azide | 1983 |
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.
Topics: Affinity Labels; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biotransformation; Carcinoma, Small Cell; Cell Survival; Dihydropyridines; Drug Resistance, Multiple; Humans; KB Cells; Lung Neoplasms; Male; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oxazines; Transplantation, Heterologous; Tritium; Vinblastine | 1998 |
Decreased expression of the type I isozyme of cAMP-dependent protein kinase in tumor cell lines of lung epithelial origin.
Topics: Adenosine Monophosphate; Affinity Labels; Animals; Azides; Blotting, Western; Cell Line; Chromatography, DEAE-Cellulose; Cyclic AMP; DNA Probes; Isoenzymes; Lung Neoplasms; Macromolecular Substances; Mice; Peptide Fragments; Protein Kinases; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured | 1990 |
Photoaffinity labeling of GDP-fucose:nLcOse4Cer alpha 1----3-fucosyltransferase from human small cell lung carcinoma NCI-H69 cells with the GDP-fucose analog GDP-hexanolaminyl-4-azidosalicylic acid.
Topics: Affinity Labels; Azides; Carcinoma, Small Cell; Cell Line; Chromatography, Affinity; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Fucosyltransferases; Guanine Nucleotides; Guanosine Diphosphate; Hexosyltransferases; Humans; Kinetics; Lung Neoplasms; Photolysis; Tumor Cells, Cultured | 1990 |
Tumor killing by human alveolar macrophages and blood monocytes. Decreased cytotoxicity of human alveolar macrophages.
Topics: Animals; Anions; Azides; Carcinoma, Bronchogenic; Cell Line; Cytotoxicity, Immunologic; Humans; Isoenzymes; Lipopolysaccharides; Luminescent Measurements; Luminol; Lung Neoplasms; Macrophages; Mice; Monocytes; Peroxidase; Peroxidases; Pulmonary Alveoli; Sarcoma, Experimental; Sodium Azide; Superoxides | 1986 |
Decreased incorporation of the photoaffinity probe 8N3-[gamma-32P]-GTP into a 45kD protein in lung tumors.
Topics: Affinity Labels; Animals; Azides; Cell Line; Guanosine Triphosphate; Lung; Lung Neoplasms; Mice; Mice, Inbred A; Molecular Weight; Neoplasm Proteins; Phosphorus Radioisotopes; Subcellular Fractions | 1987 |
Use of the oxidase electrode to determine tumor cell metabolism of peroxide.
Topics: Animals; Azides; Carcinoma, Ehrlich Tumor; Catalase; Cell Line; Ethylmaleimide; Female; Glutathione Transferase; Humans; Hydrogen Peroxide; Kinetics; Lung Neoplasms; Mice; Sodium Azide | 1986 |